Company: BLNE
Filing Date: 2025-04-14
Form Type: 424B7
Source: 0001641172-25-003933
Chunk: 0

Company: Beeline Holdings, Inc.
Filing Date: 2025-04-14
Form: 424B7
Chunk 0
---
Filed pursuant to Rule 424(b)(7)

Registration No. 333-284723

<div align='center'>Up to 266,666 Shares of Common Stock by the Selling Stockholders

Beeline Holdings, Inc.</div>

This prospectus supplement relates to up to 266,666 shares of common stock, par value $0.0001 per share, which may be issued to the two selling stockholders named herein (133,333 shares each) issuable upon conversion of the Series D Convertible Preferred Stock they hold (the “Series D”) pursuant to side letter agreements entered into by each selling stockholder and the Company on November 14, 2024 (the “Side Letters”). Pursuant to the Side Letters, each selling stockholder is entitled to convert $333,333 of stated value of Series D, or 33,333 shares of Series D, into shares of common stock at an adjusted conversion price of $2.50. By virtue of this conversion formula, each selling stockholder is entitled to receive 133,333 shares of common stock up conversion of these shares of Series D, for a total of 266,666 shares of common stock. Of that amount, 37,036 shares which were otherwise issuable pursuant to the Series D without giving effect to the conversion price adjustment resulting from the Side Letters were previously included in the base prospectus included in the registration statement to which this prospectus supplement relates, as supplemented by prior prospectus supplements. This prospectus supplement relates to such 37,036 original shares plus the 229,630 additional shares of common stock in excess of such amount issuable upon conversion of the Series D. We refer to 266,666 total shares to which this prospectus supplement relates as the “Shares.”

Our common stock is traded on The Nasdaq Capital Market under the symbol “BLNE.” On April 11, 2025, the last reported sale price of our common stock on The Nasdaq Capital Market was $1.40 per share.

As of April 11, 2025, the Company had 7,829,812 shares of common stock outstanding of which 2,023,745 shares were held by affiliates.

Each selling stockholder may be deemed to be an “underwriter” within the meaning of the Securities Act of 1933 (The “Securities Act”). The selling stockholders are offering these shares of common stock. The selling stockholders may sell all or a portion of these shares from time to time in market transactions